BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 6403228)

  • 1. Nature of the epidermal hyperplasia produced by mezerein, a weak tumor promoter, in initiated skin of mice.
    Argyris TS
    Cancer Res; 1983 Apr; 43(4):1768-73. PubMed ID: 6403228
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of 12-O-tetradecanoylphorbol-13-acetate and mezerein on epidermal ornithine decarboxylase activity, isoproterenol-stimulated levels of cyclic adenosine 3':5'-monophosphate, and induction of mouse skin tumors in vivo.
    Mufson RA; Fischer SM; Verma AK; Gleason GL; Slaga TJ; Boutwell RK
    Cancer Res; 1979 Dec; 39(12):4791-5. PubMed ID: 227591
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Studies on the mechanism of skin tumor promotion: evidence for several stages in promotion.
    Slaga TJ; Fischer SM; Nelson K; Gleason GL
    Proc Natl Acad Sci U S A; 1980 Jun; 77(6):3659-63. PubMed ID: 6774342
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epidermal cell proliferation and promoting ability of phorbol esters.
    Slaga TJ; Scribner JD; Viaje A
    J Natl Cancer Inst; 1976 Nov; 57(5):1145-9. PubMed ID: 826651
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 12-O-tetradecanoylphorbol-13-acetate promotes tumors prior to initiation in two-stage promotion.
    Ordman AB; Cleaveland JS; Boutwell RK
    Cancer Lett; 1985 Oct; 29(1):79-84. PubMed ID: 3933814
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of octahydromezerein and mezerein as protein kinase C activators and as mouse skin tumor promoters.
    Sharkey NA; Hennings H; Yuspa SH; Blumberg PM
    Carcinogenesis; 1989 Oct; 10(10):1937-41. PubMed ID: 2507191
    [TBL] [Abstract][Full Text] [Related]  

  • 7. On the role of tumour promotion in chemical carcinogenesis.
    Boutwell RK
    IARC Sci Publ; 1984; (56):3-11. PubMed ID: 6443106
    [No Abstract]   [Full Text] [Related]  

  • 8. Stages of tumour promotion in skin.
    Marks F; Fürstenberger G
    IARC Sci Publ; 1984; (56):13-22. PubMed ID: 6443102
    [No Abstract]   [Full Text] [Related]  

  • 9. Regeneration and the mechanism of epidermal tumor promotion.
    Argyris TS
    Crit Rev Toxicol; 1985; 14(3):211-58. PubMed ID: 3893895
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduced trisialoganglioside synthesis in chemically but not mos-transformed mouse epidermal cells.
    Srinivas L; Colburn NH
    Cancer Res; 1984 Apr; 44(4):1510-4. PubMed ID: 6608408
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation between sensitivity to tumor promotion and sustained epidermal hyperplasia of mice and rats treated with 12-O-tetra-decanoylphorbol-13-acetate.
    Sisskin EE; Gray T; Barrett JC
    Carcinogenesis; 1982; 3(4):403-7. PubMed ID: 6807562
    [No Abstract]   [Full Text] [Related]  

  • 12. The chlorinated pesticide mirex is a novel nonphorbol ester-type tumor promoter in mouse skin.
    Moser GJ; Meyer SA; Smart RC
    Cancer Res; 1992 Feb; 52(3):631-6. PubMed ID: 1732051
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lack of tumor promoting activity of capsaicin, a principal pungent ingredient of red pepper, in mouse skin carcinogenesis.
    Park KK; Chun KS; Yook JI; Surh YJ
    Anticancer Res; 1998; 18(6A):4201-5. PubMed ID: 9891468
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neurogenic component of phorbol ester-induced mouse skin inflammation.
    Szallasi A; Blumberg PM
    Cancer Res; 1989 Nov; 49(21):6052-7. PubMed ID: 2790819
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Skin tumor promotion by phorbol esters is a two-stage process.
    Fürstenberger G; Berry DL; Sorg B; Marks F
    Proc Natl Acad Sci U S A; 1981 Dec; 78(12):7722-6. PubMed ID: 6801661
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Specificity and mechanism(s) of promoter inhibitors in multistage promotion.
    Slaga TJ; Fischer SM; Weeks CE; Nelson K; Mamrack M; Klein-Szanto AJ
    Carcinog Compr Surv; 1982; 7():19-34. PubMed ID: 7039828
    [No Abstract]   [Full Text] [Related]  

  • 17. Squamous cell hyperplastic foci: precursors of cutaneous papillomas induced in SENCAR mice by a two-stage carcinogenesis regimen.
    Binder RL; Johnson GR; Gallagher PM; Stockman SL; Sundberg JP; Conti CJ
    Cancer Res; 1998 Oct; 58(19):4314-23. PubMed ID: 9766659
    [TBL] [Abstract][Full Text] [Related]  

  • 18. alpha-Difluoromethylornithine, an irreversible inhibitor of ornithine decarboxylase, inhibits tumor promoter-induced polyamine accumulation and carcinogenesis in mouse skin.
    Weeks CE; Herrmann AL; Nelson FR; Slaga TJ
    Proc Natl Acad Sci U S A; 1982 Oct; 79(19):6028-32. PubMed ID: 6821130
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of the epidermal growth factor receptor and transforming growth factor alpha in mouse skin carcinogenesis.
    DiGiovanni J; Rho O; Xian W; Beltràn L
    Prog Clin Biol Res; 1994; 387():113-38. PubMed ID: 7972243
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of TPA dose variation and mezerein on skin tumorigenesis by initiation promotion protocol in S/RV Cri mice.
    Bhisey RA; Veturkar PL; Jeyapaul J; Borges A
    Indian J Exp Biol; 1988 Oct; 26(10):764-7. PubMed ID: 3248829
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.